(1) Background: Walnut consumption has been associated with having a positive effect on controlling and/or reducing the co-morbidities associated with cardiovascular disease (CVD). The effects of consuming walnuts of Portuguese origin on risk factors related to CVD were evaluated by measuring glucose, urea, TC, HDL-C, LDL-C, TG, AST, and ALT levels, anthropometric profiles, and blood pressure. (2) Methods: This trial study involved 24 volunteers, both female (n = 15) and male (n = 9), from Fernando Pessoa University, Porto. It consisted of a daily intake of 25 g of walnut kernels over a period of 45 days. Before and after intake, biochemical parameters, BMI and BP were measured. (3) Results: Despite the intake of nuts revealing a reduction in mean values of most of the parameters assessed, a significant drop was only observed in AST (p = 0.04).There was also a significant reduction in the mean values for Glu (p = 0.01), UR (p = 0.01) and HDL-C (p = 0.02) for women but not for men. (4) Conclusions: The dose and the period of intake were not effective in lowering the lipid profile but may have had a protective effect on liver function. The benefits were greater in women than in men.
No takes yet. Share an insight, caveat, or question.
Soares et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: